These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38193292)

  • 1.
    Benson LN; Deck KS; Mora CJ; Guo Y; Rafferty TM; Li LX; Huang L; Andrews JT; Qin Z; Trott DW; Hoover RS; Liu Y; Mu S
    Hypertension; 2024 Mar; 81(3):530-540. PubMed ID: 38193292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IFNγ-PDL1 Pathway Enhances CD8T-DCT Interaction to Promote Hypertension.
    Benson LN; Liu Y; Wang X; Xiong Y; Rhee SW; Guo Y; Deck KS; Mora CJ; Li LX; Huang L; Andrews JT; Qin Z; Hoover RS; Ko B; Williams RM; Heller DA; Jaimes EA; Mu S
    Circ Res; 2022 May; 130(10):1550-1564. PubMed ID: 35430873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI.
    Rabadi M; Kim M; Li H; Han SJ; Choi Y; D'Agati V; Lee HT
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F293-F305. PubMed ID: 29021225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
    Safya H; Mellouk A; Legrand J; Le Gall SM; Benbijja M; Kanellopoulos-Langevin C; Kanellopoulos JM; Bobé P
    Front Immunol; 2018; 9():360. PubMed ID: 29535730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.
    Leyva-Grado VH; Ermler ME; Schotsaert M; Gonzalez MG; Gillespie V; Lim JK; García-Sastre A
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
    Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Mellouk A; Bobé P
    FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
    De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
    Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atheroprone flow activates inflammation via endothelial ATP-dependent P2X7-p38 signalling.
    Green JP; Souilhol C; Xanthis I; Martinez-Campesino L; Bowden NP; Evans PC; Wilson HL
    Cardiovasc Res; 2018 Feb; 114(2):324-335. PubMed ID: 29126223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors.
    Romagnani A; Rottoli E; Mazza EMC; Rezzonico-Jost T; De Ponte Conti B; Proietti M; Perotti M; Civanelli E; Perruzza L; Catapano AL; Baragetti A; Tenedini E; Tagliafico E; Falzoni S; Di Virgilio F; Norata GD; Bicciato S; Grassi F
    Cancer Res; 2020 Sep; 80(18):3906-3919. PubMed ID: 32699136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic receptors in tubulointerstitial inflammatory cells: a pathophysiological mechanism of salt-sensitive hypertension.
    Franco M; Bautista-Pérez R; Pérez-Méndez O
    Acta Physiol (Oxf); 2015 May; 214(1):75-87. PubMed ID: 25683649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Liu Y; Rafferty TM; Rhee SW; Webber JS; Song L; Ko B; Hoover RS; He B; Mu S
    Nat Commun; 2017 Jan; 8():14037. PubMed ID: 28067240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 modulatory web in Trypanosoma cruzi infection.
    Cascabulho CM; Menna-Barreto RF; Coutinho-Silva R; Persechini PM; Henriques-Pons A
    Parasitol Res; 2008 Sep; 103(4):829-38. PubMed ID: 18604654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human P2Y
    Dreisig K; Sund L; Dommer MW; Kristensen NP; Boddum K; Viste R; Fredholm S; Odum N; Jäättelä M; Skov S; Kornum BR
    Front Immunol; 2018; 9():1159. PubMed ID: 29937766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.
    Wang W; Hu D; Feng Y; Wu C; Song Y; Liu W; Li A; Wang Y; Chen K; Tian M; Xiao F; Zhang Q; Chen W; Pan P; Wan P; Liu Y; Lan H; Wu K; Wu J
    BMC Biol; 2020 Nov; 18(1):182. PubMed ID: 33243234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
    Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.